Robeco Institutional Asset Management B.V. grew its position in shares of Steris PLC (NYSE:STE) by 0.1% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 588,731 shares of the medical equipment provider’s stock after purchasing an additional 829 shares during the period. Robeco Institutional Asset Management B.V. owned approximately 0.70% of Steris worth $75,375,000 at the end of the most recent reporting period.
Other institutional investors have also recently modified their holdings of the company. Oregon Public Employees Retirement Fund grew its position in Steris by 10,585.0% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 3,572,743 shares of the medical equipment provider’s stock worth $33,000 after acquiring an additional 3,539,306 shares in the last quarter. Norges Bank bought a new stake in shares of Steris during the fourth quarter valued at approximately $96,648,000. Federated Investors Inc. PA raised its stake in shares of Steris by 2,546.2% during the third quarter. Federated Investors Inc. PA now owns 868,434 shares of the medical equipment provider’s stock valued at $99,348,000 after acquiring an additional 835,616 shares in the last quarter. BlackRock Inc. raised its stake in shares of Steris by 10.3% during the fourth quarter. BlackRock Inc. now owns 8,549,361 shares of the medical equipment provider’s stock valued at $913,498,000 after acquiring an additional 800,900 shares in the last quarter. Finally, Villere ST Denis J & Co. LLC bought a new stake in shares of Steris during the fourth quarter valued at approximately $63,124,000. Hedge funds and other institutional investors own 83.36% of the company’s stock.
In other Steris news, Director Mohsen Sohi sold 3,133 shares of the company’s stock in a transaction dated Tuesday, May 21st. The shares were sold at an average price of $135.94, for a total value of $425,900.02. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Jacqueline B. Kosecoff sold 3,609 shares of the company’s stock in a transaction dated Wednesday, May 15th. The stock was sold at an average price of $132.22, for a total transaction of $477,181.98. The disclosure for this sale can be found here. Insiders have sold 60,351 shares of company stock valued at $7,592,622 over the last 90 days. 2.38% of the stock is currently owned by insiders.
Shares of STE traded down $0.51 during trading hours on Wednesday, reaching $133.41. 492,331 shares of the company traded hands, compared to its average volume of 469,605. The firm has a market capitalization of $11.43 billion, a PE ratio of 27.28 and a beta of 1.06. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.27 and a quick ratio of 1.82. Steris PLC has a 12-month low of $99.14 and a 12-month high of $137.62.
Steris (NYSE:STE) last posted its earnings results on Monday, May 13th. The medical equipment provider reported $1.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.44 by $0.09. The company had revenue of $768.00 million during the quarter, compared to the consensus estimate of $738.87 million. Steris had a net margin of 10.93% and a return on equity of 13.34%. The firm’s quarterly revenue was up 7.3% on a year-over-year basis. During the same period in the previous year, the firm posted $1.24 earnings per share. As a group, research analysts anticipate that Steris PLC will post 5.38 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Wednesday, June 12th will be given a dividend of $0.34 per share. The ex-dividend date is Tuesday, June 11th. This represents a $1.36 dividend on an annualized basis and a yield of 1.02%. Steris’s dividend payout ratio is presently 27.81%.
Several brokerages recently issued reports on STE. Stephens reissued a “buy” rating and set a $135.00 price objective on shares of Steris in a report on Thursday, February 14th. Zacks Investment Research lowered shares of Steris from a “hold” rating to a “sell” rating in a report on Tuesday, March 19th. JMP Securities lifted their price objective on shares of Steris from $135.00 to $150.00 and gave the company a “market outperform” rating in a report on Wednesday, May 22nd. Finally, KeyCorp lifted their price target on shares of Steris from $135.00 to $138.00 and gave the stock an “overweight” rating in a report on Wednesday, May 15th. Five equities research analysts have rated the stock with a buy rating, The stock currently has a consensus rating of “Buy” and an average target price of $148.20.
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.
Featured Story: Why is Cost of Capital Important?
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.